Menu
- Home
+ - Publications
+
- Archives
+
- BCIQ
+
- Conferences
+
- eLearning
+
- Follow Us
Latest News
2:06 PM Jun 21, 2018
Beacon to develop right-to-try patient match platform
Beacon Pharmaceutical (New York, N.Y.) said it will launch a new platform to connect terminally ill...
2:05 PM Jun 21, 2018
UCSD launches bacteriophage treatment center
The University of California San Diego launched the Center for Innovative Phage Applications and...
1:52 PM Jun 21, 2018
Novo expands market cap on oral semaglutide data
Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) added DKK20.4 billion ($3.2 billion) in market cap in Copenhagen...
1:40 PM Jun 21, 2018
FDA releases draft guidance for antidepressant trials
FDA published draft guidance on developing drugs for major depressive disorder, which when finalized will...
11:57 AM Jun 21, 2018
Heron flying on Phase IIb pain data ahead of NDA
Heron Therapeutics Inc. (NASDAQ:HRTX) added $9.25 (30%) to $39.95 on Thursday after reporting that HTX-011...
10:48 AM Jun 21, 2018
FDA scraps biosimilars draft guidance
In an effort to reduce the cost and increase the efficiency of biosimilars development, FDA Thursday...
7:14 AM Jun 21, 2018
Rhythm raises $151.4M in follow-on
Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) raised $151.4 million through the sale of 5.7 million shares at $...
9:46 PM Jun 20, 2018
Four companies in IPO quintet post first-day gains
Four of the five biopharmas that priced IPOs late Wednesday posted gains in early afternoon trading...
4:00 PM Jun 20, 2018
Gawande to head Amazon-Berkshire-Chase healthcare company
Amazon.com Inc. (NASDAQ:AMZN), Berkshire Hathaway Inc. (NYSE:BRK.A; NYSE:BRK.B) and JPMorgan Chase &...
3:54 PM Jun 20, 2018
Broad ErbB inhibition arrests KRAS mutant cancer
Multi-ErbB inhibitors may provide a treatment option for K-Ras (KRAS)-driven lung cancer where ErbB family...
3:45 PM Jun 20, 2018
Management tracks: Sanofi, NantKwest
Sanofi (Euronext:SAN; NYSE:SNY) hired Jean-Baptiste Chasseloup de Chatillon as EVP and CFO, effective Oct....
3:40 PM Jun 20, 2018
Roche, Tesaro decline to comment on potential bid
Roche (SIX:ROG; OTCQX:RHHBY) and Tesaro Inc. (NASDAQ:TSRO) declined to comment on an Intereconomía report...
3:18 PM Jun 20, 2018
TRPV4 could be new target for brain edema
University of Tokyo researchers and colleagues found inhibiting transient receptor potential vanilloid 4 (...
2:18 PM Jun 20, 2018
Senate rejects clawback attempt
The Senate rejected a bill on Wednesday that would have rescinded more than $7 billion previously approved...
1:13 PM Jun 20, 2018
ObsEva raises $73M on heels of linzagolix data
ObsEva S.A. (NASDAQ:OBSV) raised $73.1 million through the sale of 4.8 million shares at $15.39 in a...
1:02 PM Jun 20, 2018
TG, Novimmune developing CD47/CD19 bispecific
TG Therapeutics Inc. (NASDAQ:TGTX) partnered with Novimmune S.A. (Plan-les-Ouates, Switzerland) to develop...
12:50 PM Jun 20, 2018
FDA panel to review Paratek antibiotic
FDA's Antimicrobial Drugs Advisory Committee has scheduled an Aug. 8 meeting to discuss two NDAs for...
11:45 AM Jun 20, 2018
Galmed raises $75M follow-on
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) raised $75 million through the sale of 5 million shares at $15...
7:24 AM Jun 20, 2018
Aminex raises $10M, starts Phase I cancer trial
Aminex Therapeutics Inc. (Seattle, Wash.) raised $10 million in an untranched series B round. The company...
7:15 AM Jun 20, 2018
Eidos gets first-day bump after pricing IPO at top of range
Eidos Therapeutics Inc. (NASDAQ:EIDX) added $6.12 (36%) to $23.12 Wednesday after raising $106.3 million...
About Biocentury
Contact
Support
Products & Solutions
Legal
- Follow Us
What is BioCentury?
BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.